Luo Z, Fan L, Guo W, Yang J, Li Z, Huang Y
World J Stem Cells. 2025; 17(2):100621.
PMID: 40061267
PMC: 11885945.
DOI: 10.4252/wjsc.v17.i2.100621.
Siemaszko J, Ussowicz M, Rybka B, Ryczan-Krawczyk R, Kalwak K, Bogunia-Kubik K
Front Genet. 2023; 14:1186123.
PMID: 37351346
PMC: 10282657.
DOI: 10.3389/fgene.2023.1186123.
Eichholz T, Doring M, Giardino S, Gruhn B, Seitz C, Flaadt T
Front Oncol. 2023; 13:1064190.
PMID: 36895486
PMC: 9990259.
DOI: 10.3389/fonc.2023.1064190.
Khoogar R, Li F, Chen Y, Ignatius M, Lawlor E, Kitagawa K
Cell Oncol (Dordr). 2022; 45(1):19-40.
PMID: 34997546
PMC: 10959445.
DOI: 10.1007/s13402-021-00640-x.
Costa L, Couto M, Moutinho J, Ferreira A, Costa E, Roncon S
Pediatr Rep. 2021; 13(1):125-130.
PMID: 33800180
PMC: 8006017.
DOI: 10.3390/pediatric13010018.
No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced disease.
Thiel U, Schober S, Ranft A, Gassmann H, Jabar S, Gall K
Bone Marrow Transplant. 2021; 56(7):1550-1557.
PMID: 33514918
PMC: 8263340.
DOI: 10.1038/s41409-020-01200-x.
Antiemetic Prophylaxis with Fosaprepitant and 5-HT-Receptor Antagonists in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation.
Cabanillas Stanchi K, Willier S, Vek J, Schlegel P, Queudeville M, Rieflin N
Drug Des Devel Ther. 2020; 14:3915-3927.
PMID: 33061297
PMC: 7524181.
DOI: 10.2147/DDDT.S260887.
Naïve T-cell Deficits at Diagnosis and after Chemotherapy Impair Cell Therapy Potential in Pediatric Cancers.
Das R, Vernau L, Grupp S, Barrett D
Cancer Discov. 2019; 9(4):492-499.
PMID: 30630850
PMC: 6676489.
DOI: 10.1158/2159-8290.CD-18-1314.
Rapid expansion in the WAVE bioreactor of clinical scale cells for tumor immunotherapy.
Meng Y, Sun J, Hu T, Ma Y, Du T, Kong C
Hum Vaccin Immunother. 2018; 14(10):2516-2526.
PMID: 29847223
PMC: 6284481.
DOI: 10.1080/21645515.2018.1480241.
Hematopoietic stem cell transplantation activity and trends at a pediatric transplantation center in Turkey during 1998-2008.
Hazar V, Karasu G, Uygun V, Akcan M, Kupesiz A, Yesilipek A
Turk J Haematol. 2014; 29(2):143-9.
PMID: 24744645
PMC: 3986952.
DOI: 10.5505/tjh.2012.78300.
Preimmunization of donor lymphocytes enhances antitumor immunity of autologous hematopoietic stem cell transplantation.
Suzuki K, Aida K, Miyakawa R, Narumi K, Udagawa T, Yoshida T
Cancer Med. 2014; 2(5):636-45.
PMID: 24403229
PMC: 3892795.
DOI: 10.1002/cam4.117.
Minor antigen distribution predicts site-specific graft-versus-tumor activity of adoptively transferred, minor antigen-specific CD8 T Cells.
Shand J, Qin H, Nasholm N, Capitini C, Fry T
Biol Blood Marrow Transplant. 2013; 20(1):26-36.
PMID: 24141010
PMC: 3997266.
DOI: 10.1016/j.bbmt.2013.10.009.
Autologous stem cell transplantation as first line treatment after incomplete excision of pancreatoblastoma.
Meneses C, Osorio C, de Castro Junior C, Brunetto A
Rev Bras Hematol Hemoter. 2013; 35(2):148-9.
PMID: 23741195
PMC: 3672127.
DOI: 10.5581/1516-8484.20130038.
Inhibition of STAT3 with orally active JAK inhibitor, AZD1480, decreases tumor growth in Neuroblastoma and Pediatric Sarcomas In vitro and In vivo.
Yan S, Li Z, Thiele C
Oncotarget. 2013; 4(3):433-45.
PMID: 23531921
PMC: 3717306.
DOI: 10.18632/oncotarget.930.
A pilot study of tandem high-dose chemotherapy with stem cell rescue as consolidation for high-risk neuroblastoma: Children's Oncology Group study ANBL00P1.
Seif A, Naranjo A, Baker D, Bunin N, Kletzel M, Kretschmar C
Bone Marrow Transplant. 2013; 48(7):947-52.
PMID: 23334272
PMC: 3638062.
DOI: 10.1038/bmt.2012.276.
Successful allogeneic hematopoietic cell engraftment after a minimal conditioning regimen in children with relapsed or refractory solid tumors.
Shook D, Triplett B, Srinivasan A, Hartford C, Dallas M, Pillai A
Biol Blood Marrow Transplant. 2012; 19(2):291-7.
PMID: 23063628
PMC: 4689143.
DOI: 10.1016/j.bbmt.2012.10.001.
HLA-mismatched hematopoietic stem cell tranplantation for pediatric solid tumors.
Pession A, Masetti R, Di Leo C, Franzoni M, Prete A
Pediatr Rep. 2011; 3 Suppl 2:e12.
PMID: 22053274
PMC: 3206527.
DOI: 10.4081/pr.2011.s2.e12.
Reduced-intensity allogeneic stem cell transplantation in children and young adults with ultrahigh-risk pediatric sarcomas.
Baird K, Fry T, Steinberg S, Bishop M, Fowler D, Delbrook C
Biol Blood Marrow Transplant. 2011; 18(5):698-707.
PMID: 21896345
PMC: 3262116.
DOI: 10.1016/j.bbmt.2011.08.020.